{"format":1,"id":"117-hr-2355","congress":117,"number":"H.R. 2355","kind":"bill","group":"bills","title":"Opioid Prescription Verification Act of 2021","title_source":"Short Title(s) as Passed House","official_title":"To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes."},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"Opioid Prescription Verification Act of 2021"},{"type":"Display Title","title":"Opioid Prescription Verification Act of 2021"},{"type":"Short Title(s) as Passed House","title":"Opioid Prescription Verification Act of 2021"},{"type":"Short Title(s) as Introduced","title":"Opioid Prescription Verification Act of 2021"},{"type":"Short Title(s) as Reported to House","title":"Opioid Prescription Verification Act of 2021"}],"outcome":"passed_house","law_number":null,"introduced":"2021-04-05","chambers":{"house":{"status":"roll_call","date":"2021-12-08","vote":{"id":"117-2021-h422","question":"On Motion to Suspend the Rules and Pass, as Amended","title":"Opiod Prescription Verification Act","result":"Passed","yea":410,"nay":15,"present":0,"not_voting":8,"source":"https://clerk.house.gov/evs/2021/roll422.xml"}},"senate":{"status":"na","date":null,"vote":null}},"president":{"status":"na","date":null},"vice_president_tie_breaker":null,"latest_action":{"text":"Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.","date":"2021-12-09"},"nominees":null,"amendments":[],"other_votes":[],"crs_summary":{"date":"2021-12-08","stage":"Passed House","blocks":[{"k":"h","t":"Opioid Prescription Verification Act of 2021"},{"k":"p","t":"This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC)."},{"k":"p","t":"Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications."},{"k":"p","t":"In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that"},{"k":"li","t":"maintain a prescription drug monitoring program that mandates the collection of specified information,","d":1},{"k":"li","t":"require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and","d":1},{"k":"li","t":"require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.","d":1}],"words":123},"summary":{"main_subject":{"text":"Directs the Secretary of Health and Human Services to include patient identity verification in pharmacist training materials, and lets the CDC Director give preference to States with certain prescription drug monitoring and electronic prescribing requirements when determining overdose prevention grant amounts.","cites":[{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H915B08E2ED3F4C789C87B9366B7C91B1"},{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H79AECFE561404C109118B9A1BB0B8257"}]},"core_areas":["Pharmacist training materials on verifying patient identity","CDC overdose prevention grants to States and State prescription drug monitoring programs"],"what_it_does":[{"text":"Amends section 3212(a) of the SUPPORT for Patients and Communities Act so the Secretary of Health and Human Services updates the pharmacist training materials periodically after the original one-year deadline.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H915B08E2ED3F4C789C87B9366B7C91B1"}},{"text":"Adds to the training materials a paragraph on training pharmacists on how to verify the identity of the patient.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H915B08E2ED3F4C789C87B9366B7C91B1"}},{"text":"Requires the Secretary of Health and Human Services, not later than 1 year after enactment and after seeking stakeholder input, to update the materials to include information for pharmacists on verifying patient identity and to disseminate them as appropriate.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H915B08E2ED3F4C789C87B9366B7C91B1"}},{"text":"Allows the Director of the Centers for Disease Control and Prevention, in setting the amounts of grants to States under section 392A of the Public Health Service Act, to give preference under criteria the Director specifies.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H79AECFE561404C109118B9A1BB0B8257"}},{"text":"Lists States that maintain a prescription drug monitoring program and that require electronic prescribing of schedule II, III, or IV controlled substances, with exceptions listed in section 1860D–4(e)(7)(B) of the Social Security Act, as States the Director may choose to prefer.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H79AECFE561404C109118B9A1BB0B8257"}},{"text":"Lists States that require dispensers to enter the National Drug Code or compound identifier, quantity dispensed, patient identifier, and date filled into the State's prescription drug monitoring program as States the Director may choose to prefer.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh#H79AECFE561404C109118B9A1BB0B8257"}}],"unexpected":[],"version":{"type":"Engrossed in House","date":"2021-12-08","rule":"passed","href":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text/eh"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-10-15","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/117th-congress/house-bill/2355","text":"https://www.congress.gov/bill/117th-congress/house-bill/2355/text"},"card":{"image":"card/item/117-hr-2355.png","v":"f93d4b9a662b","alt":"Votes on Record. H.R. 2355, 117th Congress: Opioid Prescription Verification Act of 2021. House: 410 Yea, 15 Nay. Outcome: Passed House, 8 Dec 2021."}}